Explore 3 Stock Ideas & Industry Insights Download Free Report

Conavi Medical Corp.

Company price
0.105 CAD -0.01 ( 4.55%)
Last update at 2026-11-04T20:32:00Z
VOLUME
72537
Market Cap
47.05M

Momentum Score

…

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.12
High
52 Week Price Range
0.35
Low
0.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Conavi Medical Corp. is a small-cap medical-technology company that develops coronary physiology and imaging solutions; public disclosures are limited. Long-term growth drivers could include adoption of physiology-guided revascularization, regulatory approvals, clinical validation and commercial partnerships to support uptake. Investors may find exposure to a large coronary disease market with potential for recurring procedure-related revenue.
The primary investment risk is early-stage commercial and regulatory execution, including reliance on clinical validation, limited financial resources, potential dilution and competitive pressure from established diagnostic platforms.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.11
Dividend Yield
-
Revenue TTM
0.71M
Revenue Per Share
0.01
Gross Profit TTM
0.76M
Debt / Equity
-
ROE
-
Net Debt
12.53M
ROCE
-350.95%
Diluted EPS TTM
-0.22

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30
Type yearly yearly
Date 2025-09-30 2024-09-30
Income before tax -20.52M -43.62M
Net income -20.52M -43.62M
Selling general administrative 6.15M 7.07M
Gross profit 7.63M 0.05M
Reconciled depreciation 0.81M 0.99M
Operating income -14.85M -26.23M
Interest expense 11.69M 8.02M
Interest income 0.14M 0.25M
Net interest income -11.44M -7.76M
Total revenue 9.12M 2.16M
Total operating expenses 23.97M 28.39M
Cost of revenue 1.50M 2.11M
Total other income expense net 5.78M -9.62M
Net income from continuing ops -20.52M -43.62M
Breakdown 2025-09-30 2024-09-30
Type yearly yearly
Date 2025-09-30 2024-09-30
Total assets 12.44M 8.56M
Intangible assets 2.15M -
Total liab 30.47M 94.39M
Total stockholder equity -18.03M -85.83M
Other current liab 2.79M -
Capital stock 126.79M 35.96M
Retained earnings -167.00M -146.49M
Cash 5.84M 0.44M
Total current liabilities 8.21M 28.19M
Net debt 12.53M 45.93M
Short long term debt 1.11M 21.80M
Total current assets 8.27M 3.53M
Net receivables 0.41M 0.67M
Long term debt 17.27M 24.56M
Inventory 0.34M 1.61M
Accounts payable 2.90M 6.00M
Non current assets total 4.17M 5.03M
Capital lease obligations 1.53M 1.26M
Breakdown 2025-09-30 2024-09-30
Type yearly yearly
Date 2025-09-30 2024-09-30
Net borrowings -1.53M 7.26M
Total cash from financing activities 26.93M 7.26M
Net income -20.52M -43.62M
Change in cash 5.40M -13.73M
Begin period cash flow 0.44M 14.17M
End period cash flow 5.84M 0.44M
Total cash from operating activities -25.10M -20.15M
Issuance of capital stock 22.16M 0.00M
Depreciation 0.81M 0.99M
Change to inventory 1.27M 1.39M
Change to account receivables 0.69M 0.06M
Capital expenditures 0.18M 0.85M
Change in working capital -3.66M 4.55M
Stock based compensation 0.44M 0.26M
Other non cash items -2.68M 7.43M
Free cash flow -25.28M -21.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
CNVI
Conavi Medical Corp.
-0.01
4.55%
0.10 - - 66.65 - 95.30
TLT
Theralase Technologies Inc.
0.01
2.78%
0.18 - - 90.07 82.51 90.31
PINK
Perimeter Medical Imaging AI Inc
-
-%
0.18 4.13 - 18.78 11.34 20.22
CHER
Cheelcare Inc.
-
-%
1.25 - - 20.92 106.42 21.26
ASG
Aurora Spine Corp
-0.01
13.04%
0.10 - - 1.19 4.07 1.02

Profile*

Conavi Medical Corp.

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.

293 Lesmill Road, Toronto, ON, Canada, M3B 2V1

Name Title Year Born
Mr. Thomas Looby CEO & Director 1972
Mr. Stefano Picone CFO & Corporate Secretary 1983
Mr. Robert Skidmore Vice President of Operations 1953
Dr. Amandeep Thind Chief Technology Officer 1980
Mr. Travis More Vice President of Human Resources 1969
Mr. Sumeet Dham Vice President of Research and Development 1972
Mr. Stefano Picone Chief Strategy Officer & Corporate Secretary 1983
Mr. Mark Quick Chief Financial Officer NA
John Lefavour Vice President of Operations NA
Mr. Sumeet Dham Vice President of Research and Development 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…